BRIEF published on 06/17/2024 at 18:20, 2 years ago Roche Bobois: Repurchase of own shares in June 2024 Euronext Own Shares Redemption Roches Bobois
PRESS RELEASE published on 06/17/2024 at 18:15, 2 years ago RACHAT D'ACTIONS PROPRES Roche Bobois SA procède au rachat d'actions propres autorisé par l'assemblée générale. Détails des transactions du 10 au 14 juin 2024 et chiffres clés de l'entreprise Chiffre D'affaires Rachat D'actions Transactions Financières Roche Bobois SA Entreprise Familiale
BRIEF published on 06/17/2024 at 17:50, 2 years ago Information Mensuelle Relative aux Droits de Vote chez ROCHE BOBOIS Capital Droits De Vote AMF Information Mensuelle Roche Bobois
BRIEF published on 06/17/2024 at 17:50, 2 years ago Monthly Information Relating to Voting Rights at ROCHE BOBOIS Voting Rights Capital Monthly Information AMF Roche Bobois
PRESS RELEASE published on 06/17/2024 at 17:45, 2 years ago INFORMATION MENSUELLE RELATIVE AUX DROITS DE VOTE Annonce des informations relatives aux droits de vote de l' e e RBO et itre de Roche Bobois SA avec son chiffre d'affaires consolidé et pr sentation de l'entreprise Chiffre D'affaires Droits De Vote Roche Bobois SA Entreprise Familiale ISIN FR0013344173
BRIEF published on 06/10/2024 at 17:50, 2 years ago Roche Bobois annonce un rachat d'actions propres Rachat D'actions Euronext Transactions Financières Programme De Rachat Roche Bobois Le 7 Juin, 122 Actions À 48,45 € Le 6 Juin, 87 Actions À 48,8241 € Le 5 Juin, 1 004 Actions À 48,7357 € Le 4 Juin, 198 Actions À 49 € Le 3 Juin, 200 Actions À 48,955 €
BRIEF published on 06/10/2024 at 17:50, 2 years ago Roche Bobois announces a buyback of its own shares Euronext Share Buyback Financial Transactions Buyback Program Roche Bobois June 7, 122 Shares At €48.45 On June 6, 87 Shares At €48.8241 On June 5, 1,004 Shares At €48.7357 June 4, 198 Shares At €49 June 3, 200 Shares At €48.955
PRESS RELEASE published on 06/10/2024 at 17:45, 2 years ago RACHAT D'ACTIONS PROPRES Roche Bobois SA a réalisé des transactions de rachat d'actions propres du 3 au 7 juin 2024. Tous les détails sont disponibles sur leur site. Roche Bobois est spécialisé dans l'ameublement haut de gamme et a un CA consolidé de 429,6 M€ en 2023 Rachat D'actions Finance Investisseurs Roche Bobois SA Ameublement Haut De Gamme
BRIEF published on 06/03/2024 at 18:05, 2 years ago Roche Bobois annonce un rachat d'actions propres Actions Propres Rachat D'actions Euronext 2024 Roche Bobois
BRIEF published on 06/03/2024 at 18:05, 2 years ago Roche Bobois announces a buyback of its own shares Euronext Share Buyback Own Shares 2024 Roche Bobois
Published on 06/26/2026 at 14:05, 15 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 20 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 1 hour 20 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 01:40, 12 hours 40 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/26/2026 at 14:00, 19 minutes ago Hong Kong celebrates surge of global enterprises driving investment and opportunities
Published on 06/26/2026 at 14:00, 20 minutes ago Bitcoin Group SE publishes 2025 Annual Report: Strategic realignment ensures future viability in the dynamic crypto market
Published on 06/26/2026 at 13:32, 47 minutes ago Porsche ranks number one in J.D. Power 2026 U.S. Initial Quality Study
Published on 06/26/2026 at 13:30, 49 minutes ago Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share
Published on 06/26/2026 at 13:30, 49 minutes ago AlphaESS Unveils Expanded Energy Storage Ecosystem for Europe at Intersolar 2026
Published on 06/26/2026 at 07:00, 7 hours 20 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 7 hours 20 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 19 hours 34 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 19 hours 50 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
